BRTI Life Sciences to provide “tissue-like” microenvironment to support pancreatic islets for JDRF funded University of Minnesota study.

BRTI Life Sciences to provide “tissue-like” microenvironment to support pancreatic islets for JDRF funded University of Minnesota study.

BRTI Life Sciences’ unique 3D matrix will be included in a study at the University of Minnesota of immunoisolated islets in a structured biomimetic environment to treat insulin-dependent diabetes. The study, which is fully funded by the Juvenile Diabetes Research Foundation (JDRF), employs a device, including islets embedded in BRTI’s unique microenvironment, that will be implanted under the skin of nonhuman primates. The device is designed to eliminate the need for immunosuppression drugs to protect the islets.  This novel approach may lower the cost and risk of islet transplantation for patients with insulin-dependent diabetes, freeing them from the need for routine insulin injections.
To learn more, see the JDRF funded abstract.